Brian D Hosfield1, Anthony R Pecoraro1, Nielson T Baxter2, Troy B Hawkins2, Troy A Markel3. 1. Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. 2. Elanco Animal Health, Greenfield, Indiana. 3. Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: tmarkel@iupui.edu.
Abstract
BACKGROUND: The assessment of fecal volatile organic compounds (VOCs) has emerged as a noninvasive biomarker in many different pathologies. Before assessing whether VOCs can be used to diagnose intestinal diseases, including necrotizing enterocolitis (NEC), it is necessary to measure the impact of variable infant demographic factors on VOC signals. MATERIALS AND METHODS: Stool samples were collected from term infants at four hospitals in a large metropolitan area. Samples were heated, and fecal VOCs assessed by the Cyranose 320 Electronic Nose. Twenty-eight sensors were combined into an overall smellprint and were also assessed individually. 16s rRNA gene sequencing was used to categorize infant microbiomes. Smellprints were correlated to feeding type (formula versus breastmilk), sex, hospital of birth, and microbial enterotype. Overall smellprints were assessed by PERMANOVA with Euclidean distances, and individual sensors from each smellprint were assessed by Mann-Whitney U-tests. P < 0.05 was significant. RESULTS: Overall smellprints were significantly different according to diet. Individual sensors were significantly different according to sex and hospital of birth, but overall smellprints were not significantly different. Using a decision tree model, two individual sensors could reliably predict microbial enterotype. CONCLUSIONS: Assessment of fecal VOCs with an electronic nose is impacted by several demographic characteristics of infants and can be used to predict microbiome composition. Further studies are needed to design appropriate algorithms that are able to predict NEC based on fecal VOC profiles.
BACKGROUND: The assessment of fecal volatile organic compounds (VOCs) has emerged as a noninvasive biomarker in many different pathologies. Before assessing whether VOCs can be used to diagnose intestinal diseases, including necrotizing enterocolitis (NEC), it is necessary to measure the impact of variable infant demographic factors on VOC signals. MATERIALS AND METHODS: Stool samples were collected from term infants at four hospitals in a large metropolitan area. Samples were heated, and fecal VOCs assessed by the Cyranose 320 Electronic Nose. Twenty-eight sensors were combined into an overall smellprint and were also assessed individually. 16s rRNA gene sequencing was used to categorize infant microbiomes. Smellprints were correlated to feeding type (formula versus breastmilk), sex, hospital of birth, and microbial enterotype. Overall smellprints were assessed by PERMANOVA with Euclidean distances, and individual sensors from each smellprint were assessed by Mann-Whitney U-tests. P < 0.05 was significant. RESULTS: Overall smellprints were significantly different according to diet. Individual sensors were significantly different according to sex and hospital of birth, but overall smellprints were not significantly different. Using a decision tree model, two individual sensors could reliably predict microbial enterotype. CONCLUSIONS: Assessment of fecal VOCs with an electronic nose is impacted by several demographic characteristics of infants and can be used to predict microbiome composition. Further studies are needed to design appropriate algorithms that are able to predict NEC based on fecal VOC profiles.
Authors: Christopher Quince; Elin E Lundin; Anna N Andreasson; Dario Greco; Joseph Rafter; Nicholas J Talley; Lars Agreus; Anders F Andersson; Lars Engstrand; Mauro D'Amato Journal: Gut Date: 2013-01-07 Impact factor: 23.059
Authors: Sofie Bosch; Daniel J Berkhout; Ilhame Ben Larbi; Tim G de Meij; Nanne K de Boer Journal: J Cancer Res Clin Oncol Date: 2018-12-15 Impact factor: 4.553
Authors: Tim G de Meij; Ilhame Ben Larbi; Marc P van der Schee; Yvette E Lentferink; Tamara Paff; Jochim S Terhaar Sive Droste; Chris J Mulder; Adriaan A van Bodegraven; Nanne K de Boer Journal: Int J Cancer Date: 2013-09-02 Impact factor: 7.396
Authors: Catherine E Garner; Andrew K Ewer; Kalifa Elasouad; Francis Power; Rosemary Greenwood; Norman M Ratcliffe; Ben de Lacy Costello; Chris S Probert Journal: J Pediatr Gastroenterol Nutr Date: 2009-11 Impact factor: 2.839
Authors: Tim G J de Meij; Nanne K H de Boer; Marc A Benninga; Yvette E Lentferink; Evelien F J de Groot; Mirjam E van de Velde; Adriaan A van Bodegraven; Marc P van der Schee Journal: J Crohns Colitis Date: 2014-09-22 Impact factor: 9.071
Authors: Emma Dixon; Cynthia Clubb; Sara Pittman; Larry Ammann; Zeehasham Rasheed; Nazia Kazmi; Ali Keshavarzian; Pat Gillevet; Huzefa Rangwala; Robin D Couch Journal: PLoS One Date: 2011-04-08 Impact factor: 3.240
Authors: Sofie Bosch; Sofia El Manouni El Hassani; James A Covington; Alfian N Wicaksono; Marije K Bomers; Marc A Benninga; Chris J J Mulder; Nanne K H de Boer; Tim G J de Meij Journal: Anal Chem Date: 2018-06-15 Impact factor: 6.986
Authors: Brian D Hosfield; Natalie A Drucker; Anthony R Pecoraro; William C Shelley; Hongge Li; Nielson T Baxter; Troy B Hawkins; Troy A Markel Journal: J Pediatr Surg Date: 2021-02-24 Impact factor: 2.549